Ming‐Yu Cao

Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.

Ming‐Yu Cao, Yoon Seong Lee, Ningping Feng et al. · PubMed · 2003 · 36 citations

Tumor Biology, Ribonucleotide Reductase, Human Colon Adenocarcinoma +15

11-Phenyl-[b,e]-dibenzazepine compounds: Novel antitumor agents

Raed A. Al‐Qawasmeh, Yoon Lee, Ming‐Yu Cao et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 31 citations

Molecular Pharmacology, Medicinal Chemistry, Novel Antitumor Agents +7

NC381, a Novel Anticancer Agent, Arrests the Cell Cycle in G0-G1 and Inhibits Lung Tumor Cell Growth in Vitro and in Vivo

Ming‐Yu Cao, Yoon Lee, Ningping Feng et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 21 citations

HLA Class II-Associated Genetic Susceptibility in Idiopathic Progressive Sensorineural Hearing Loss

Joëlle Thonnard, Ming‐Yu Cao, Naïma Deggouj et al. · Annals of Otology Rhinology & Laryngology · 1996 · 20 citations

Allergy, Genetic Disorder, Genetics +15

Detection of inner ear disease autoantibodies by immunoblotting

Ming‐Yu Cao, M Gersdorff, Na�ma Deggouj et al. · Molecular and Cellular Biochemistry · 1995 · 19 citations

Autoimmune Disease, Allergy, Diagnosis +6